{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:18Z","timestamp":1787020818735,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174088"],"award-info":[{"award-number":["82174088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21974107"],"award-info":[{"award-number":["21974107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Project of Yunnan Characteristic Plant Extraction Laboratory","award":["YKKF202310"],"award-info":[{"award-number":["YKKF202310"]}]},{"name":"Key Research and Development Plan of Shaanxi Province","award":["2024SF-YBXM-461"],"award-info":[{"award-number":["2024SF-YBXM-461"]}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2021-04-22-005"],"award-info":[{"award-number":["2021-04-22-005"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022-SLRH-YQ-007"],"award-info":[{"award-number":["2022-SLRH-YQ-007"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cutaneous hypertrophic scar is a fibro-proliferative hard-curing disease. Recent studies have proved that antagonists of angiotensin II type 1 receptor (AT\n                      <jats:sub>1<\/jats:sub>\n                      R) and agonists of type 2 receptor (AT\n                      <jats:sub>2<\/jats:sub>\n                      R) were able to relieve hypertrophic scar. Therefore, establishing new methods to pursue dual-target lead compounds from Chinese herbs is in much demand for treating scar.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      To this end, we immobilized AT\n                      <jats:sub>1<\/jats:sub>\n                      R or AT\n                      <jats:sub>2<\/jats:sub>\n                      R onto the surface of silica gel from cell lysates through a specific covalent bond by bioorthogonal chemistry. The columns containing immobilized AT\n                      <jats:sub>1<\/jats:sub>\n                      R or AT\n                      <jats:sub>2<\/jats:sub>\n                      R were jointly utilized to pursue potential bioactive compounds simultaneously binding to AT\n                      <jats:sub>1<\/jats:sub>\n                      R and AT\n                      <jats:sub>2<\/jats:sub>\n                      R from the extract of Rhei Radix et Rhizoma. Their functions on AT\n                      <jats:sub>1<\/jats:sub>\n                      R and AT\n                      <jats:sub>2<\/jats:sub>\n                      R expressions were investigated by in vitro and in vivo experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Aloe-emodin and emodin were identified as the potential bioactive compounds binding to both of the two receptors, thereby improving the appearance and pathomorphology of hypertrophic scar. They blocked the AT\n                      <jats:sub>1<\/jats:sub>\n                      R pathway to down-regulate the expression of transforming growth factor-\u03b21 (TGF-\u03b21) and stimulate matrix metalloproteinase-1 (MMP-1) expression. As such, the expression of collagen I\/III reduced. Conversely, the bindings of the two compounds to AT\n                      <jats:sub>2<\/jats:sub>\n                      R reduced the production of nuclear factor-\u043aB1 (NF-\u043aB1), whereby the generation of interleukin-6 (IL-6) was blocked.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We reasoned that aloe-emodin and emodin had the potential to become dual-target candidates against hypertrophic scar through the regulation of AT\n                      <jats:sub>1<\/jats:sub>\n                      R and AT\n                      <jats:sub>2<\/jats:sub>\n                      R signaling pathways. It showed considerable potential to become a universal strategy for pursuing multi-target bioactive compounds from Chinese herbs by the utilization of diverse immobilized receptors in a desired order.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01065-6","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T02:28:15Z","timestamp":1737944895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A strategy for selective screening of dual-target bioactive compounds against hypertrophic scar through inhibiting angiotensin II type 1 receptor while stimulating type 2 receptor from Chinese herbs"],"prefix":"10.1186","volume":"20","author":[{"given":"Lejing","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"issue":"3","key":"1065_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/ijms19030711","volume":"19","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Jang YJ. Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. Int J Mol Sci. 2018;19(3):711.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1065_CR2","doi-asserted-by":"publisher","first-page":"79e","DOI":"10.1097\/PRS.0000000000008667","volume":"149","author":"R Ogawa","year":"2022","unstructured":"Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022;149(1):79e\u201394e.","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"1065_CR3","first-page":"1139","volume":"11","author":"JA Wagner","year":"2013","unstructured":"Wagner JA. Therapy of pathological scars. J Dtsch Dermatol Ges. 2013;11(12):1139\u201357.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"1065_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/wrr.12648","volume":"26","author":"K Hedayatyanfard","year":"2018","unstructured":"Hedayatyanfard K, Ziai SA, Niazi F, Habibi I, Habibi B, Moravvej H. Losartan ointment relieves hypertrophic scars and keloid: a pilot study. Wound Repair Regen. 2018;26(4):340\u20133.","journal-title":"Wound Repair Regen"},{"issue":"5","key":"1065_CR5","doi-asserted-by":"publisher","first-page":"686e","DOI":"10.1097\/PRS.0000000000003800","volume":"140","author":"J Chisholm","year":"2017","unstructured":"Chisholm J, Gareau AJ, Byun S, Paletz JL, Tang D, Williams J, et al. Effect of compound 21, a selective angiotensin II type 2 receptor agonist, in a murine xenograft model of dupuytren disease. Plast Reconstr Surg. 2017;140(5):686e-96e.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"1065_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.0906-6705.2004.0139.x","volume":"13","author":"UM Steckelings","year":"2004","unstructured":"Steckelings UM, Wollschlager T, Peters J, Henz BM, Hermes B, Artuc M. Human skin: source of and target organ for angiotensin II. Exp Dermatol. 2004;13(3):148\u201354.","journal-title":"Exp Dermatol"},{"issue":"10","key":"1065_CR7","first-page":"36","volume":"11","author":"F Niazi","year":"2018","unstructured":"Niazi F, Hooshyar SH, Hedayatyanfard K, Ziai SA, Doroodgar F, Niazi S, et al. Detection of angiotensin II and AT(1) receptor concentrations in keloid and hypertrophic scar. J Clin Aesthet Dermatol. 2018;11(10):36\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"9","key":"1065_CR8","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1016\/j.apsb.2021.03.016","volume":"11","author":"X Ning","year":"2021","unstructured":"Ning X, Wiraja C, Chew WTS, Fan C, Xu C. Transdermal delivery of Chinese herbal medicine extract using dissolvable microneedles for hypertrophic scar treatment. Acta Pharm Sin B. 2021;11(9):2937\u201344.","journal-title":"Acta Pharm Sin B"},{"key":"1065_CR9","doi-asserted-by":"publisher","first-page":"1025602","DOI":"10.3389\/fphar.2022.1025602","volume":"13","author":"D Chen","year":"2022","unstructured":"Chen D, Li Q, Zhang H, Kou F, Li Q, Lyu C, et al. Traditional Chinese medicine for hypertrophic scars-A review of the therapeutic methods and potential effects. Front Pharmacol. 2022;13:1025602.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1065_CR10","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1021\/acs.analchem.9b01268","volume":"91","author":"J Wang","year":"2019","unstructured":"Wang J, Wang Y, Liu J, Li Q, Yin G, Zhang Y, et al. Site-specific immobilization of beta(2)-AR using O(6)-benzylguanine derivative-functionalized supporter for high-throughput receptor-targeting lead discovery. Anal Chem. 2019;91(11):7385\u201393.","journal-title":"Anal Chem"},{"key":"1065_CR11","doi-asserted-by":"publisher","first-page":"463298","DOI":"10.1016\/j.chroma.2022.463298","volume":"1677","author":"A Shayiranbieke","year":"2022","unstructured":"Shayiranbieke A, Liang Q, Wang T, Ma J, Li G, Du X, et al. Development of immobilized beta1-adrenoceptor chromatography for rapid discovery of ligands specifically binding to the receptor from herbal extract. J Chromatogr A. 2022;1677:463298.","journal-title":"J Chromatogr A"},{"key":"1065_CR12","doi-asserted-by":"publisher","first-page":"462827","DOI":"10.1016\/j.chroma.2022.462827","volume":"1665","author":"X Yuan","year":"2022","unstructured":"Yuan X, Shayiranbieke A, Xu R, Jiang H, Yang Y, Zhang Y, et al. Site-selective covalently immobilized alpha 1A adrenergic receptor for thermodynamic and extra-thermodynamic study of four ligands binding to the receptor by chromatographic methods. J Chromatogr A. 2022;1665:462827.","journal-title":"J Chromatogr A"},{"key":"1065_CR13","doi-asserted-by":"publisher","first-page":"462443","DOI":"10.1016\/j.chroma.2021.462443","volume":"1653","author":"X Zhao","year":"2021","unstructured":"Zhao X, Fu X, Yuan X, Shayiranbieke A, Xu R, Cao F, et al. Development and characterization of a selective chromatographic approach to the rapid discovery of ligands binding to muscarinic-3 acetylcholine receptor. J Chromatogr A. 2021;1653:462443.","journal-title":"J Chromatogr A"},{"issue":"20","key":"1065_CR14","doi-asserted-by":"publisher","first-page":"13750","DOI":"10.1021\/acs.analchem.0c01807","volume":"92","author":"X Zhao","year":"2020","unstructured":"Zhao X, Jin Y, Yuan X, Hou Z, Chen Z, Fu X, et al. Covalent inhibitor-based one-step method for endothelin receptor a immobilization: from ligand recognition to lead identification. Anal Chem. 2020;92(20):13750\u20138.","journal-title":"Anal Chem"},{"issue":"2","key":"1065_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1039\/C7SC03887A","volume":"9","author":"K Zeng","year":"2018","unstructured":"Zeng K, Li Q, Wang J, Yin G, Zhang Y, Xiao C, et al. One-step methodology for the direct covalent capture of GPCRs from complex matrices onto solid surfaces based on the bioorthogonal reaction between haloalkane dehalogenase and chloroalkanes. Chem Sci. 2018;9(2):446\u201356.","journal-title":"Chem Sci"},{"key":"1065_CR16","doi-asserted-by":"publisher","first-page":"461946","DOI":"10.1016\/j.chroma.2021.461946","volume":"1640","author":"X Fu","year":"2021","unstructured":"Fu X, Li L, Wen X, Xu R, Xue Y, Zuo H, et al. Halo-tagged protein immobilization: effect of halide linkers on peak profile and drug-protein interaction. J Chromatogr A. 2021;1640:461946.","journal-title":"J Chromatogr A"},{"issue":"13","key":"1065_CR17","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1021\/acs.analchem.8b00214","volume":"90","author":"Q Li","year":"2018","unstructured":"Li Q, Ning X, An Y, Stanley BJ, Liang Y, Wang J, et al. Reliable analysis of the interaction between specific ligands and immobilized beta-2-adrenoceptor by adsorption energy distribution. Anal Chem. 2018;90(13):7903\u201311.","journal-title":"Anal Chem"},{"issue":"1","key":"1065_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jamcollsurg.2007.03.001","volume":"205","author":"ZB Kryger","year":"2007","unstructured":"Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, Mustoe TA. Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surg. 2007;205(1):78\u201388.","journal-title":"J Am Coll Surg"},{"key":"1065_CR19","doi-asserted-by":"publisher","first-page":"102715","DOI":"10.1016\/j.ebiom.2020.102715","volume":"54","author":"Y Feng","year":"2020","unstructured":"Feng Y, Wu JJ, Sun ZL, Liu SY, Zou ML, Yuan ZD, et al. Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation. EBioMedicine. 2020;54:102715.","journal-title":"EBioMedicine"},{"issue":"7","key":"1065_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.tibtech.2011.03.002","volume":"29","author":"JL Baneres","year":"2011","unstructured":"Baneres JL, Popot JL, Mouillac B. New advances in production and functional folding of G-protein-coupled receptors. Trends Biotechnol. 2011;29(7):314\u201322.","journal-title":"Trends Biotechnol"},{"issue":"2","key":"1065_CR21","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1124\/pr.112.007278","volume":"65","author":"MC Michel","year":"2013","unstructured":"Michel MC, Foster C, Brunner HR, Liu L. A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev. 2013;65(2):809\u201348.","journal-title":"Pharmacol Rev"},{"issue":"6","key":"1065_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.CIR.103.6.904","volume":"103","author":"M Burnier","year":"2001","unstructured":"Burnier M. Angiotensin II type 1 receptor blockers. Circulation. 2001;103(6):904\u201312.","journal-title":"Circulation"},{"issue":"2","key":"1065_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/hr.2012.147","volume":"36","author":"S Miura","year":"2013","unstructured":"Miura S, Okabe A, Matsuo Y, Karnik SS, Saku K. Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan. Hypertens Res. 2013;36(2):134\u20139.","journal-title":"Hypertens Res"},{"issue":"8","key":"1065_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/pharmaceutics12080735","volume":"12","author":"EM Tottoli","year":"2020","unstructured":"Tottoli EM, Dorati R, Genta I, Chiesa E, Pisani S, Conti B. Skin wound healing process and new emerging technologies for skin wound care and regeneration. Pharmaceutics. 2020;12(8):735.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1065_CR25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-beta in tissue fibrosis. J Exp Med. 2020;217(3): e20190103.","journal-title":"J Exp Med"},{"issue":"11","key":"1065_CR26","first-page":"S40","volume":"10","author":"R Ardaillou","year":"1999","unstructured":"Ardaillou R, Chansel D, Chatziantoniou C, Dussaule JC. Mesangial AT1 receptors: expression, signaling, and regulation. J Am Soc Nephrol. 1999;10(11):S40\u20136.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1065_CR27","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0002-9440(10)63422-0","volume":"165","author":"H Takeda","year":"2004","unstructured":"Takeda H, Katagata Y, Hozumi Y, Kondo S. Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol. 2004;165(5):1653\u201362.","journal-title":"Am J Pathol"},{"issue":"5","key":"1065_CR28","doi-asserted-by":"publisher","first-page":"803e","DOI":"10.1097\/PRS.0000000000006173","volume":"144","author":"A Murphy","year":"2019","unstructured":"Murphy A, LeVatte T, Boudreau C, Midgen C, Gratzer P, Marshall J, et al. Angiotensin II type I receptor blockade is associated with decreased cutaneous scar formation in a rat model. Plast Reconstr Surg. 2019;144(5):803e-13e.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"1065_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1210\/en.2003-0673","volume":"145","author":"LJ Min","year":"2004","unstructured":"Min LJ, Cui TX, Yahata Y, Yamasaki K, Shiuchi T, Liu HW, et al. Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes. Endocrinology. 2004;145(1):253\u201360.","journal-title":"Endocrinology"},{"issue":"1","key":"1065_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13020-021-00509-z","volume":"16","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Li S, Li X, Liu R. Advances in the study of emodin: an update on pharmacological properties and mechanistic basis. Chin Med. 2021;16(1):102.","journal-title":"Chin Med"},{"key":"1065_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13020-020-00370-6","volume":"15","author":"H Xiang","year":"2020","unstructured":"Xiang H, Zuo J, Guo F, Dong D. What we already know about rhubarb: a comprehensive review. Chin Med. 2020;15:88.","journal-title":"Chin Med"},{"issue":"12","key":"1065_CR32","first-page":"1618","volume":"47","author":"Q Wang","year":"2012","unstructured":"Wang Q, Zhang NN, Li HY, Jiang M, Gao J, Bai G. Active ingredients in rhubarb with anti-proliferative effects on scar fibroblasts. Yao Xue Xue Bao. 2012;47(12):1618\u201322.","journal-title":"Yao Xue Xue Bao"},{"issue":"6","key":"1065_CR33","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.3892\/mmr.2015.3265","volume":"11","author":"C Liu","year":"2015","unstructured":"Liu C. Inhibition of mechanical stress-induced hypertrophic scar inflammation by emodin. Mol Med Rep. 2015;11(6):4087\u201392.","journal-title":"Mol Med Rep"},{"issue":"8","key":"1065_CR34","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2021e11184","volume":"54","author":"Z Xia","year":"2021","unstructured":"Xia Z, Wang J, Yang S, Liu C, Qin S, Li W, et al. Emodin alleviates hypertrophic scar formation by suppressing macrophage polarization and inhibiting the Notch and TGF-beta pathways in macrophages. Braz J Med Biol Res. 2021;54(8): e11184.","journal-title":"Braz J Med Biol Res"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01065-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01065-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T02:28:22Z","timestamp":1737944902000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01065-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01065-6","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were authorized by the Animal Care and Use Committee of Northwest University in China (No. NWU-AWC-20221104L).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}